Biotech Archives - Page 727 of 795

1 minute read

Amarin Touts Positive Data For Its Heart Disease Drug In Current/Former Smokers

August 29, 7:16 AM

Amarin Corporation plc (NASDAQ:AMRN) announced that new REDUCE-IT data show that Vascepa/Vazkepa (icosapent ethyl) significantly reduced cardiovascular (CV) events in patients…

AMRN

2 minute read

Novartis Scemblix Approved by the European Commission for Adult Patients with Chronic Myeloid Leukemia

By Charles Gross

August 29, 5:08 AM

Novartis today announced that the European Commission (EC) has approved Scemblix® (asciminib) for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP), previously treated with two or more tyrosine kinase inhibitors (TKIs)1.Novartis today announced that the European Commission (EC) has approved Scemblix® (asciminib) for th

NVS

3 minute read

Recap Of Friday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

August 26, 7:52 PM

The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor…

BCRX

1 minute read

Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed

By Vandana Singh

August 26, 1:15 PM

According to the World Health Organization, health officials are witnessing early signs that the new monkeypox case growth may be…

AEMD

1 minute read

Biomea Fusion Touts Additional Preclinical Data For Blood Cancer Candidate

By Vandana Singh

August 26, 1:13 PM

Biomea Fusion Inc (NASDAQ: BMEA) announced the presentation of two posters at the 19th International Myeloma Society (IMS) Annual Meeting.

BMEA

1 minute read

Novavax Scores Another Nod For Its COVID-19 Shot In Adolescents

By Vandana Singh

August 26, 12:46 PM

The Medicines and Healthcare products Regulatory Agency in the U.K. has granted expanded conditional approval for Novavax Inc’s (NASDAQ:NVAX) COVID-19 vaccine, Nuvaxovid…

NVAX

1 minute read

Pfizer/BioNTech Complete European Submission For Omicron Subvariant Adapted Vaccine

By Vandana Singh

August 26, 12:41 PM

Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have completed a submission to the European Medicines Agency (EMA) for a booster dose of an…

BNTX

1 minute read

Amarin’s New Vascepa Data Shows Significant Reduction In Heart Attack Subtypes

By Vandana Singh

August 26, 12:08 PM

New data shows that Amarin Corporation plc's (NASDAQ: AMRN) Vascepa/Vazkepa (icosapent ethyl) significantly reduced ST-segment and non-ST elevation myocardial infarction (NSTEMI) and other MI subtypes in patients with cardiovascular disease or diabetes with risk factors.

AMRN

1 minute read

‘Monkeypox Outbreak Shows Signs of Cooling in U.S. and Globally’ -WSJ Report

By Benzinga Newsdesk

August 26, 11:47 AM

https://www.wsj.com/articles/monkeypox-outbreak-shows-signs-of-cooling-in-u-s-and-globally-11661526042?mod=e2tw

AEMD

1 minute read

Novavax Obtains U.K. Regulatory Clearance For Nuvaxovid In Adolescents Aged 12-17 Years

By Ragothaman Srinivasan

August 26, 11:42 AM

The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has granted expanded conditional marketing authorization (CMA) for Novavax’s (NASDAQ: NVAX) lead asset Nuvaxovid (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caus

NVAX